Stoke Therapeutics (STOK) Q2 2023 Earnings

7AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.7
-0.64
-0.59
-0.53

Details

Expected EPS
-0.64
Actual EPS
-0.69
Surprise EPS
-0.05
Surprise Percent
+7.81%

Description

Stoke Therapeutics (STOK) has reported earnings of -0.69 per share for Q2 2023.

0 Comments

Share your thoughts